These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9702418

  • 21. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
    Glossop JR, Dawes PT, Nixon NB, Mattey DL.
    Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
    [Abstract] [Full Text] [Related]

  • 22. [Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis].
    Tesar V, Jelínková E, Jirsa M, Bakosová N, Pit'ha V, Chábová V.
    Cas Lek Cesk; 1998 Nov 02; 137(21):654-9. PubMed ID: 9929930
    [Abstract] [Full Text] [Related]

  • 23. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C, André B, Kaye O, Kaiser MJ, Bonnet V, de Groote D, Franchimont N, Malaise MG.
    Eur Cytokine Netw; 2000 Dec 02; 11(4):669-76. PubMed ID: 11125312
    [Abstract] [Full Text] [Related]

  • 24. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.
    Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM.
    Immunology; 1992 May 02; 76(1):20-3. PubMed ID: 1321092
    [Abstract] [Full Text] [Related]

  • 25. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
    Kacprzyk F.
    Pol Merkur Lekarski; 2003 Oct 02; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
    [Abstract] [Full Text] [Related]

  • 26. Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma.
    Su TR, Chang KL, Lee CH, Chen CH, Yang YH, Shieh TY.
    Oral Oncol; 2004 Sep 02; 40(8):804-10. PubMed ID: 15288835
    [Abstract] [Full Text] [Related]

  • 27. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep 02; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

  • 28. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
    Jablonska E.
    Mediators Inflamm; 2002 Oct 02; 11(5):325-8. PubMed ID: 12467526
    [Abstract] [Full Text] [Related]

  • 29. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting.
    Wei M, Kuukasjärvi P, Laurikka J, Pehkonen E, Kaukinen S, Laine S, Tarkka M.
    Cytokine; 2001 Aug 21; 15(4):223-8. PubMed ID: 11563882
    [Abstract] [Full Text] [Related]

  • 30. TNFRs and IL-6R transmembrane receptors expression and release of their soluble forms by neutrophils and mononuclear cells from cancer patients.
    Jabłońska E, Jabioński J, Hołownia A, Iwaszkiewicz-Pawłowska A, Piotrowski L, Kiluk M, Grabowska SZ, Markiewicz W.
    Rocz Akad Med Bialymst; 2001 Aug 21; 46():113-25. PubMed ID: 11780554
    [Abstract] [Full Text] [Related]

  • 31. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A, Urbańska-Ryś H, Robak T.
    Br J Haematol; 1999 May 21; 105(2):412-9. PubMed ID: 10233412
    [Abstract] [Full Text] [Related]

  • 32. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 21; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 33. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 34. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
    Scudla V, Budíková M, Bacovský J, Opíchalová D, Farbiaková V.
    Cas Lek Cesk; 2000 Jul 05; 139(13):401-6. PubMed ID: 10971970
    [Abstract] [Full Text] [Related]

  • 35. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients.
    Sadeghi M, Daniel V, Naujokat C, Mehrabi A, Opelz G.
    Transplantation; 2006 Jun 27; 81(12):1716-24. PubMed ID: 16794539
    [Abstract] [Full Text] [Related]

  • 36. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection.
    Weiss M, Martignoni M, Petropoulou T, Sölder B, Belohradsky BH.
    Infection; 1996 Jun 27; 24(4):301-8. PubMed ID: 8875282
    [Abstract] [Full Text] [Related]

  • 37. Interleukin 6, tumor necrosis factor alpha and their soluble receptors in the blood serum of patients with denture stomatitis and fungal infection.
    Pietruski JK, Pietruska MD, Jabłońska E, Sacha P, Zaremba M, Stokowska W.
    Arch Immunol Ther Exp (Warsz); 2000 Jun 27; 48(2):101-5. PubMed ID: 10807050
    [Abstract] [Full Text] [Related]

  • 38. Human soluble tumor necrosis factor receptor I (sTNF-RI) and interleukin-I receptor antagonist (IL-I Ra) in different stages of acute rheumatic fever.
    Kütükçüler N, Karaca NE, Sözeri BY, Koturoğlu G, Kurugöl Z, Ozyürek RA, Aksu G.
    Anadolu Kardiyol Derg; 2008 Apr 27; 8(2):139-42. PubMed ID: 18400635
    [Abstract] [Full Text] [Related]

  • 39. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.
    Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF.
    J Allergy Clin Immunol; 2001 Jan 27; 107(1):165-70. PubMed ID: 11150007
    [Abstract] [Full Text] [Related]

  • 40. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L.
    Pol Merkur Lekarski; 2001 Jul 27; 11(61):19-25. PubMed ID: 11579824
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.